Policies Targeting ‘Rebate Traps’ In Part D May Not Yield Big Savings, Study Suggests

Research on generic drug coverage in Medicare Part D plans finds access unobstructed for majority of lower cost alternatives. However, study may offer incomplete picture, generic and biosimilar advocates say.